# Micro RNAs to Predict Response to Androgen Deprivation Therapy

> **NCT02366494** · — · COMPLETED · sponsor: **Medical College of Wisconsin** · enrollment: 42 (actual)

## Conditions studied

- Prostate Cancer

## Interventions

- **DRUG:** Bicalutamide
- **DRUG:** Leuprolide
- **DRUG:** Goserelin
- **DRUG:** Triptorelin
- **DRUG:** Docetaxel
- **DRUG:** Abiraterone
- **DRUG:** Apalutamide
- **DRUG:** Enzalutamide

## Key facts

- **NCT ID:** NCT02366494
- **Lead sponsor:** Medical College of Wisconsin
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2015-04-29
- **Primary completion:** 2021-05-11
- **Final completion:** 2021-05-11
- **Target enrollment:** 42 (ACTUAL)
- **Last updated:** 2024-11-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02366494

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02366494, "Micro RNAs to Predict Response to Androgen Deprivation Therapy". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT02366494. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*